refining biomarker-based therapies for her2 gastric or gastroesophageal junction cancer
Published 3 weeks ago • 24 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:27
biomarker-driven treatment strategies for her2 g/gej junction cancer
-
3:42
key biomarkers for advanced gastric cancer therapy decision-making
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
3:12
advances in her2-targeted therapies for gastric cancer
-
0:44
biomarker-based personalization for her2-low breast cancer treatment in destiny-breast04
-
2:45
current and future biomarkers for gastroesophageal cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
0:48
fgfr2b: a novel biomarker for patients with gastroesophageal cancer
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
0:38
current biomarker testing guidelines for colorectal cancer
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
2:27
neoaltto: her2/cep17 ratio as a predictive biomarker in her breast cancer
-
46:04
webinar on "biomarkers in gastric cancer”
-
2:20
her2 in gastric cancer
-
10:07
importance of biomarkers when evaluating heterogeneity in her2 metastatic bc
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
4:21
subito: iact vs conventional chemotherapy for her2-, hrd breast cancer
-
5:24
emerging biomarkers in metastatic gastric cancer